NGL Fine-chem
NGL delivered strong volume-led revenue growth but faces margin pressure from new Tarapur facility costs.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every NGL Fine-chem earnings call we streamed: the live audio and our summary of what management said.
NGL delivered strong volume-led revenue growth but faces margin pressure from new Tarapur facility costs.
NGL delivered strong volume-led revenue growth but faces margin pressure from new Tarapur facility costs.
Management expects 30-40% utilization at Tarapur over next 2-3 quarters, targeting FY28-30 for critical mass.
NGL Fine-Chem reported strong Q4 FY26 results with 57% YoY revenue growth and significant margin expansion. Management focuses on capacity expansion and penetrating regulated markets (Europe/US).
NGL Fine Chem reports a strong recovery in FY26, driven by higher volumes and expanded intermediate production. However, management remains cautious about returning to peak historical margins due to persistent global competition and cost pressures.
NGL Fine-Chem delivered strong FY26 performance with revenue up 36% to ₹501cr and PAT up 127% to ₹48cr, driven by volume growth in the animal health segment.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.